Poseida Therapeutics Investor Relations Material

Poseida Therapeutics, Inc. (PSTX) is a clinical-stage biopharmaceutical company that specializes in developing innovative cell and gene therapies. These therapies aim to provide cures for cancers and genetic diseases by leveraging non-viral gene engineering technologies. Poseida's product pipeline includes both autologous and allogeneic chimeric antigen receptor T cell (CAR-T) therapies, which are at the forefront of treating hematological malignancies and solid tumors. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.